Connect with us

Business

Company Patents Cannabinoid-Releasing Chewing Gum

It’s a perfect storm situation for AXIM Biotechnologies. July 9, The FDA
announced serious
warnings for NSAIDs anti-inflammatory drugs- drugs which AXIM say their
medicated gum can replace. AXIM&n

Published

on

 

gum

[dropcap class=”kp-dropcap”]I[/dropcap]t’s a perfect storm situation for AXIM Biotechnologies. July 9, The FDA announced serious warnings for NSAIDs anti-inflammatory drugs- drugs which AXIM say their medicated gum can replace. AXIM  recently acquired intellectual rights for a U.S. patent for time-release cannabidiol chewing gum. CanChew Biotechnologies will hold the patent for production with a 50 year licensing agreement with AXIM. AXIM is strategically entering the market at the right time. AXIM’s new focus is to introduce proprietary delivery mechanisms for the introduction of cannabinoids. The company is known for green alternative hemp energy among other innovations and has been developing their patent-pending cannabinoid delivery system at the Free University of Amsterdam.

AXIM claims to have found a way to bypass first-pass liver metabolism and the insolubility of cannabinoids. Dr. George E. Anastossov, CEO of AXIM Biotechnologies, told Yahoo Finance, “AXIM’s business focus has been and continues to be on being an innovative biotechnology company working on solutions for the treatment of pain, spasticity, anxiety and other medical disorders and symptoms with the application of cannabinoid-based products as well as focusing on research, development and production of pharmaceutical, nutraceutical, oral health and cosmetic products as well as procurement of genetically and nano-controlled active ingredients.”

Axim Biotech recently unveiled its patent for cannabis chewing gum at the My Compassion Cannabis Conference in Chicago. “We sincerely appreciate My Compassion hosting the 2nd Annual Chicago Cannabis Conference and including AXIM Biotech as a presenter on cannabinoid delivery methods,” Anastassov told Globe Newswire. “We were able to educate healthcare and legal professionals, patients and the news media. It was an invaluable experience and AXIM looks forward to supporting My Compassion in the future.”

AXIM’s patent-pending nanotech extraction techniques seem quite capable of altering and improving current methods of ingestion. Three cheers for innovation.

 

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *